Biotricity, Inc. (BTCY) Financial Statements (2024 and earlier)

Company Profile

Business Address 203 REDWOOD PARKWAY
REDWOOD CITY, CA 94065
State of Incorp. NV
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
3/31/2023
12/31/2022
MRQ
3/31/2022
3/31/2021
3/31/2020
3/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments57045112,0672,20295064
Cash and cash equivalents57045112,0672,20295064
Receivables1,2241,9752,0071,521486208
Inventory, net of allowances, customer advances and progress billings2,3371,9328432728625
Inventory2,3371,9328432728625
Deposits current assets589436406327137101
Other undisclosed current assets      60
Total current assets:4,7204,79415,3234,3221,659458
Noncurrent Assets
Operating lease, right-of-use asset1,5871,6731,24366264
Property, plant and equipment222327   
Long-term investments and receivables9672    
Accounts and financing receivable, after allowance for credit loss9672    
Deposits noncurrent assets858585 3333
Other undisclosed noncurrent assets    5048 
Total noncurrent assets:1,7901,8531,35511634633
TOTAL ASSETS:6,5116,64716,6784,4382,004491
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,0423,4902,5962,5201,5221,401
Accounts payable3,435 1,1591,0411,094878
Accrued liabilities1,6071,1071,4361,479428522
Other undisclosed accounts payable and accrued liabilities 2,384    
Debt4,7743,1261,5404,2782,068 
Derivative instruments and hedges, liabilities1,0083525213,634  
Due to related parties 204    
Other undisclosed current liabilities33611921058213 
Total current liabilities:11,1617,2914,86710,4903,8031,401
Noncurrent Liabilities
Long-term debt and lease obligation13,05012,63513,603 57 
Long-term debt, excluding current maturities13,05012,63512,483   
Liabilities, other than long-term debt2,1462,2033524101,145 
Operating lease, liability1,3861,4611,120 57
Derivative instruments and hedges, liabilities7597423524101,145 
Other undisclosed noncurrent liabilities    371  
Total noncurrent liabilities:15,19514,83813,9567811,202 
Other undisclosed liabilities      868
Total liabilities:26,35622,12918,82311,2715,0052,268
Equity
Equity, attributable to parent, including:(19,845)(15,482)(2,145)(6,833)(3,000)(1,778)
Preferred stock 000 00
Common stock535251393635
Additional paid in capital92,80192,29791,50756,29944,01533,890
Accumulated other comprehensive loss(153)(143)(769)(634)(857)(755)
Accumulated deficit(112,571)(107,713)(93,037)(62,818)(46,364)(35,039)
Other undisclosed equity, attributable to parent252510228116991
Other undisclosed equity      
Total equity:(19,845)(15,482)(2,145)(6,833)(3,000)(1,778)
TOTAL LIABILITIES AND EQUITY:6,5116,64716,6784,4382,004491

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
3/31/2023
12/31/2022
TTM
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Revenues9,63912,3497,6503,3851,418398
Cost of revenue(4,197)(4,949)(3,080)(1,871)(725)(249)
Gross profit:5,4427,4004,5701,514692150
Operating expenses(20,852)(28,476)(22,591)(14,865)(11,623)(8,742)
Operating loss:(15,410)(21,076)(18,020)(13,352)(10,931)(8,592)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(111)(127)15(37)  
Interest and debt expense(1,910)(86)(380)1,200  
Other undisclosed loss from continuing operations before equity method investments, income taxes (380)    
Loss from continuing operations before equity method investments, income taxes:(17,431)(21,669)(18,385)(12,188)(10,931)(8,592)
Other undisclosed income (loss) from continuing operations before income taxes(1,227)(11,428)(10,746)(3,303)(136) 
Loss from continuing operations:(18,658)(33,097)(29,130)(15,491)(11,067)(8,592)
Loss before gain (loss) on sale of properties:(28,580)(29,130)(15,491)(11,067)(8,592)
Other undisclosed net loss      
Net loss:(18,658)(33,097)(29,130)(15,491)(11,067)(8,592)
Other undisclosed net income attributable to parent      
Net loss attributable to parent:(18,658)(33,097)(29,130)(15,491)(11,067)(8,592)
Preferred stock dividends and other adjustments(876)(1,130)(1,089)(962)(258) 
Other undisclosed net income available to common stockholders, basic  0  0 
Net loss available to common stockholders, diluted:(19,534)(34,227)(30,219)(16,453)(11,325)(8,592)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
3/31/2023
12/31/2022
TTM
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Net loss:(18,658)(33,097)(29,130)(15,491)(11,067)(8,592)
Comprehensive loss:(18,658)(33,097)(29,130)(15,491)(11,067)(8,592)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(260)(826)(1,223)(146,839)(360)(112)
Comprehensive loss, net of tax, attributable to parent:(18,918)(33,923)(30,354)(162,330)(11,427)(8,704)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: